Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
Akin AbayomiAkin OsibogunOluchi Kanma-OkaforJide IdrisAbimbola BowaleOlolade WrightBisola AdebayoMobolanle BalogunSegun OgboyeRemi AdeseunIsmael Abdus-SalamBamidele MutiuBabatunde SakaDayo LajideSam YenyiRotimi AgbolagoriteOluwatosin OnasanyaEniola ErinoshoJoshua ObasanyaOlu AdejumoSunday AdesolaYewande OshodiIorhen E AkaseShina OgunbiyiAdenike OmosunFemi ErinosoHussein Abdur-RazzaqNike OsaKingsley AkinroyePublished in: Global health research and policy (2021)
The potential morbidity and mortality risks of hypertension especially with other comorbidities in COVID-19 could help direct efforts towards prevention and prognostication. This provides the rationale for improving preventive caution for people with hypertension and other comorbidities and prioritizing them for future antiviral interventions.